Racura Oncology Ltd (ASX:RAC)
Australia
· Delayed Price · Currency is AUD 2.380
+0.040 (1.71%)
Mar 10, 2026, 12:17 PM AEST
Racura Oncology Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 20.94 | 13.67 | 17.19 | 21.52 | 33.54 | 9.32 | Upgrade
|
| Cash & Short-Term Investments | 20.94 | 13.67 | 17.19 | 21.52 | 33.54 | 9.32 | Upgrade
|
| Cash Growth | 11.50% | -20.50% | -20.13% | -35.84% | 259.79% | 438.63% | Upgrade
|
| Other Receivables | - | 0.03 | 0.11 | 1.7 | 0.06 | 0.13 | Upgrade
|
| Receivables | 0.03 | 0.03 | 0.11 | 1.7 | 0.06 | 0.13 | Upgrade
|
| Prepaid Expenses | 0.26 | 1.26 | 0.12 | 0.32 | 0.55 | 1.14 | Upgrade
|
| Total Current Assets | 21.23 | 14.96 | 17.42 | 23.54 | 34.15 | 10.59 | Upgrade
|
| Other Intangible Assets | 2.39 | 2.53 | 2.81 | 3.09 | 3.37 | 3.66 | Upgrade
|
| Total Assets | 24.77 | 17.49 | 20.23 | 26.64 | 37.52 | 14.25 | Upgrade
|
| Accounts Payable | 0.17 | 0.46 | 1.2 | 0.64 | 0.83 | 0.31 | Upgrade
|
| Accrued Expenses | 0.8 | 0.97 | 0.67 | 0.51 | 0.58 | 0.21 | Upgrade
|
| Other Current Liabilities | 0.18 | 0.02 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 1.16 | 1.45 | 1.87 | 1.15 | 1.42 | 0.52 | Upgrade
|
| Other Long-Term Liabilities | 0.04 | 0.02 | 0.05 | - | - | - | Upgrade
|
| Total Liabilities | 1.2 | 1.48 | 1.92 | 1.15 | 1.42 | 0.52 | Upgrade
|
| Common Stock | 81.6 | 68.49 | 66.95 | 61.71 | 62.02 | 31.5 | Upgrade
|
| Retained Earnings | -66.3 | -62.21 | -57.42 | -43.6 | -33.68 | -22.47 | Upgrade
|
| Comprehensive Income & Other | 8.28 | 9.73 | 8.78 | 7.38 | 7.77 | 4.69 | Upgrade
|
| Shareholders' Equity | 23.57 | 16.01 | 18.31 | 25.49 | 36.11 | 13.72 | Upgrade
|
| Total Liabilities & Equity | 24.77 | 17.49 | 20.23 | 26.64 | 37.52 | 14.25 | Upgrade
|
| Net Cash (Debt) | 20.94 | 13.67 | 17.19 | 21.52 | 33.54 | 9.32 | Upgrade
|
| Net Cash Growth | 11.50% | -20.50% | -20.13% | -35.84% | 259.79% | 438.63% | Upgrade
|
| Net Cash Per Share | 0.12 | 0.08 | 0.10 | 0.13 | 0.22 | 0.07 | Upgrade
|
| Filing Date Shares Outstanding | 180.82 | 173.74 | 170.39 | 163.07 | 159.52 | 144.4 | Upgrade
|
| Total Common Shares Outstanding | 180.82 | 173.74 | 170.3 | 163.07 | 159.52 | 143.65 | Upgrade
|
| Working Capital | 20.07 | 13.51 | 15.55 | 22.39 | 32.73 | 10.07 | Upgrade
|
| Book Value Per Share | 0.13 | 0.09 | 0.11 | 0.16 | 0.23 | 0.10 | Upgrade
|
| Tangible Book Value | 21.18 | 13.48 | 15.5 | 22.39 | 32.73 | 10.07 | Upgrade
|
| Tangible Book Value Per Share | 0.12 | 0.08 | 0.09 | 0.14 | 0.21 | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.